// App-Quantinova.ai

2414 : Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjögren’s Syndrome – Open-label Extension Phase of a Randomized Controlled Phase III Trial

Researchers

Presenter

  • Esther Mossel

Principal Investigators

  • Robin Wijnsma

  • Greetje van Zuiden

  • Konstantina Delli

  • Alja Stel

  • Bert van der vegt

  • Erlin Haacke

  • Lisette Olie

  • Leonie Los

  • Gwenny Verstappen

  • Sarah Pringle

  • Fred Spijkervet

  • Frans Kroese

  • Arjan Vissink

  • Suzanne Arends

  • Hendrika Bootsma

Medical Centers

  • University Medical Center, University of Groningen, Groningen, Netherlands

  • Dept. of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

  • University of Groningen, Groningen, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Prednisone

  • Abatacept

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Open Label

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved